MedTrace Logo

Motivated Behavior in Adults With and Without ADHD

NCT02630017 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-08-27

Study results available
· View outcomes & findings →

Summary

To investigate the effects of methylphenidate on motivated behavior in adults with and without ADHD

Conditions

  • ADHD

Interventions

DRUG

ADHD methylphenidate first, placebo second

double-blind, counter-balanced administration

DRUG

ADHD placebo first, methylphenidate second

double-blind, counter-balanced administration

DRUG

Non-ADHD methylphenidate first, placebo second

double-blind, counter-balanced administration

DRUG

Non-ADHD placebo first, methylphenidate second

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Merideth A Addicott, PhD · University of Arkansas

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-07
Primary Completion
2018-09-21
Completion
2018-09-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02630017 on ClinicalTrials.gov